Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethality
Shu Wang(Georgetown Lombardi Comprehensive Cancer Center), Britt Skogseid(Uppsala University), Christer Betsholtz(Uppsala University), Ricardo Feinstein(Swedish Veterinary Agency), Catharina Larsson(Karolinska University Hospital), Yinghua Zhou(Uppsala University Hospital), Peter Stålberg(Uppsala University Hospital), Kjell Öberg(Uppsala University Hospital), Samuel Gebré‐Medhin(University of Gothenburg), Anders Gobl(Uppsala University Hospital), Günther Weber(Goethe University Frankfurt)
Cited by 48
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Role of platelet-derived growth factors in physiology and medicine
|Genes & Development|2008|2.4k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
|Arteriosclerosis Thrombosis and Vascular Biology|2009|916